abstract |
Novel inhibitors of urokinase are provided by formula (I), which have an arginine or arginine mimic aldehyde or an arginine ketoamide group. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions that are ameliorated by inhibition of or decreased activity of urokinase |